Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Tutor Perini Slips To Loss In Q1; Backs FY12 Outlook - Quick Facts

RELATED NEWS
Trade TPC now with 

Tutor Perini Corp. (TPC: Quote) reported that its first-quarter net loss was $1.2 million, compared to net income of $6.9 million for the first quarter of 2011. Loss per common share was $0.03 for the first quarter of 2012, compared to earnings of $0.14 for the first quarter of 2011.

Operating results for the quarter were negatively impacted by $3.6 million of discrete tax adjustments related to stock-based compensation and a $2.7 million loss on the sale of certain auction rate securities which, together, contributed non-recurring charges in the quarter of $0.11 per share.

xcluding these items the Company earned an adjusted $0.08 per share, reflecting the substantial completion of several large successful projects in 2011, coupled with the timing of approval of change orders on certain Civil segment jobs, delays related to the timing of new awards, and the startup of pending awards.

Revenues from construction operations were $912.5 million for the first quarter of 2012, as compared to $615.3 million for the first quarter of 2011.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.42 per share on revenues of $1.10 billion for the quarter. Analysts' estimates typically exclude special items.

Excluding the non-recurring items, guidance for the full-year 2012 is estimated to be in the range previously provided. Revenues are estimated to be in the range of $4.5 billion to $5.0 billion and earnings per share are estimated to be in the range of $2.10 to $2.30 per share. Analysts expect the company to report earnings of $2.17 per share on revenues of $4.61 billion for fiscal 2012.

Register
To receive FREE breaking news email alerts for Tutor Perini Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.